nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—ABCB1—melanoma	0.285	1	CbGaD
Trimipramine—CYP3A4—Temozolomide—melanoma	0.0655	0.284	CbGbCtD
Trimipramine—CYP2D6—Vemurafenib—melanoma	0.0564	0.245	CbGbCtD
Trimipramine—ABCB1—Dactinomycin—melanoma	0.0398	0.173	CbGbCtD
Trimipramine—CYP3A4—Vemurafenib—melanoma	0.0359	0.156	CbGbCtD
Trimipramine—HTR1D—meninx—melanoma	0.0221	0.428	CbGeAlD
Trimipramine—ABCB1—Docetaxel—melanoma	0.0205	0.0892	CbGbCtD
Trimipramine—CYP3A4—Docetaxel—melanoma	0.0123	0.0534	CbGbCtD
Trimipramine—Tongue discolouration—Temozolomide—melanoma	0.00414	0.0238	CcSEcCtD
Trimipramine—Extrapyramidal disorder—Temozolomide—melanoma	0.00266	0.0153	CcSEcCtD
Trimipramine—HTR2A—hindlimb—melanoma	0.00261	0.0505	CbGeAlD
Trimipramine—HTR1D—blood vessel—melanoma	0.00251	0.0485	CbGeAlD
Trimipramine—Petechiae—Temozolomide—melanoma	0.00243	0.014	CcSEcCtD
Trimipramine—Eosinophilia—Vemurafenib—melanoma	0.00243	0.014	CcSEcCtD
Trimipramine—HTR2A—appendage—melanoma	0.00224	0.0433	CbGeAlD
Trimipramine—Neuropathy peripheral—Vemurafenib—melanoma	0.00215	0.0124	CcSEcCtD
Trimipramine—Coordination abnormal—Carmustine—melanoma	0.00211	0.0121	CcSEcCtD
Trimipramine—Coordination abnormal—Temozolomide—melanoma	0.00204	0.0117	CcSEcCtD
Trimipramine—Disorientation—Bleomycin—melanoma	0.00192	0.0111	CcSEcCtD
Trimipramine—Gynaecomastia—Carmustine—melanoma	0.00185	0.0107	CcSEcCtD
Trimipramine—Throat sore—Docetaxel—melanoma	0.00185	0.0106	CcSEcCtD
Trimipramine—Oropharyngeal discomfort—Docetaxel—melanoma	0.00183	0.0105	CcSEcCtD
Trimipramine—Cerebrovascular accident—Bleomycin—melanoma	0.00176	0.0101	CcSEcCtD
Trimipramine—Alopecia—Vemurafenib—melanoma	0.00174	0.01	CcSEcCtD
Trimipramine—Benazepril—SLC15A2—melanoma	0.00168	0.356	CrCbGaD
Trimipramine—Dysgeusia—Vemurafenib—melanoma	0.00168	0.00965	CcSEcCtD
Trimipramine—Vascular purpura—Temozolomide—melanoma	0.00162	0.00935	CcSEcCtD
Trimipramine—Purpura—Temozolomide—melanoma	0.00151	0.00868	CcSEcCtD
Trimipramine—Oropharyngeal pain—Docetaxel—melanoma	0.00146	0.00843	CcSEcCtD
Trimipramine—Pancytopenia—Bleomycin—melanoma	0.00141	0.00814	CcSEcCtD
Trimipramine—Ataxia—Carmustine—melanoma	0.00141	0.00814	CcSEcCtD
Trimipramine—Ataxia—Temozolomide—melanoma	0.00137	0.00787	CcSEcCtD
Trimipramine—HTR2A—endothelium—melanoma	0.00135	0.0261	CbGeAlD
Trimipramine—HTR1D—eye—melanoma	0.00133	0.0258	CbGeAlD
Trimipramine—Pancytopenia—Dactinomycin—melanoma	0.00132	0.00759	CcSEcCtD
Trimipramine—Acute coronary syndrome—Bleomycin—melanoma	0.00131	0.00753	CcSEcCtD
Trimipramine—Hypotension—Vemurafenib—melanoma	0.0013	0.00752	CcSEcCtD
Trimipramine—Myocardial infarction—Bleomycin—melanoma	0.0013	0.00749	CcSEcCtD
Trimipramine—Stomatitis—Bleomycin—melanoma	0.00129	0.00745	CcSEcCtD
Trimipramine—HTR2A—blood vessel—melanoma	0.00125	0.0241	CbGeAlD
Trimipramine—Pancytopenia—Carmustine—melanoma	0.00123	0.0071	CcSEcCtD
Trimipramine—Decreased appetite—Vemurafenib—melanoma	0.00121	0.00699	CcSEcCtD
Trimipramine—Stomatitis—Dactinomycin—melanoma	0.00121	0.00695	CcSEcCtD
Trimipramine—Fatigue—Vemurafenib—melanoma	0.0012	0.00694	CcSEcCtD
Trimipramine—Constipation—Vemurafenib—melanoma	0.00119	0.00688	CcSEcCtD
Trimipramine—Pancytopenia—Temozolomide—melanoma	0.00119	0.00687	CcSEcCtD
Trimipramine—Hypoaesthesia—Bleomycin—melanoma	0.00118	0.00683	CcSEcCtD
Trimipramine—Pollakiuria—Temozolomide—melanoma	0.00116	0.00668	CcSEcCtD
Trimipramine—Erectile dysfunction—Temozolomide—melanoma	0.00116	0.00666	CcSEcCtD
Trimipramine—Agranulocytosis—Dactinomycin—melanoma	0.00115	0.00665	CcSEcCtD
Trimipramine—Weight increased—Temozolomide—melanoma	0.00114	0.00658	CcSEcCtD
Trimipramine—Neuropathy peripheral—Carmustine—melanoma	0.00113	0.00654	CcSEcCtD
Trimipramine—Stomatitis—Carmustine—melanoma	0.00113	0.0065	CcSEcCtD
Trimipramine—Flushing—Bleomycin—melanoma	0.00111	0.00637	CcSEcCtD
Trimipramine—Body temperature increased—Vemurafenib—melanoma	0.0011	0.00636	CcSEcCtD
Trimipramine—Neuropathy peripheral—Temozolomide—melanoma	0.0011	0.00632	CcSEcCtD
Trimipramine—Stomatitis—Temozolomide—melanoma	0.00109	0.00628	CcSEcCtD
Trimipramine—Alopecia—Bleomycin—melanoma	0.00105	0.00606	CcSEcCtD
Trimipramine—ADRA1B—head—melanoma	0.00104	0.02	CbGeAlD
Trimipramine—Hypoaesthesia—Carmustine—melanoma	0.00103	0.00596	CcSEcCtD
Trimipramine—Hallucination—Carmustine—melanoma	0.00103	0.00596	CcSEcCtD
Trimipramine—Flushing—Dactinomycin—melanoma	0.00103	0.00594	CcSEcCtD
Trimipramine—DRD2—eye—melanoma	0.001	0.0194	CbGeAlD
Trimipramine—Asthenia—Vemurafenib—melanoma	0.001	0.00577	CcSEcCtD
Trimipramine—Hallucination—Temozolomide—melanoma	0.000999	0.00576	CcSEcCtD
Trimipramine—Hypoaesthesia—Temozolomide—melanoma	0.000999	0.00576	CcSEcCtD
Trimipramine—DRD2—retina—melanoma	0.000996	0.0193	CbGeAlD
Trimipramine—Pruritus—Vemurafenib—melanoma	0.000988	0.00569	CcSEcCtD
Trimipramine—Alopecia—Dactinomycin—melanoma	0.000981	0.00565	CcSEcCtD
Trimipramine—Flushing—Carmustine—melanoma	0.000965	0.00556	CcSEcCtD
Trimipramine—Ill-defined disorder—Bleomycin—melanoma	0.000962	0.00554	CcSEcCtD
Trimipramine—Diarrhoea—Vemurafenib—melanoma	0.000955	0.0055	CcSEcCtD
Trimipramine—Tinnitus—Temozolomide—melanoma	0.000936	0.0054	CcSEcCtD
Trimipramine—Malaise—Bleomycin—melanoma	0.000935	0.00539	CcSEcCtD
Trimipramine—HTR3A—head—melanoma	0.000932	0.018	CbGeAlD
Trimipramine—Flushing—Temozolomide—melanoma	0.000932	0.00537	CcSEcCtD
Trimipramine—Arrhythmia—Carmustine—melanoma	0.000928	0.00535	CcSEcCtD
Trimipramine—Dizziness—Vemurafenib—melanoma	0.000923	0.00532	CcSEcCtD
Trimipramine—Alopecia—Carmustine—melanoma	0.000918	0.00529	CcSEcCtD
Trimipramine—Ataxia—Docetaxel—melanoma	0.000908	0.00523	CcSEcCtD
Trimipramine—Ill-defined disorder—Dactinomycin—melanoma	0.000897	0.00517	CcSEcCtD
Trimipramine—HTR2A—neck—melanoma	0.000891	0.0172	CbGeAlD
Trimipramine—Vomiting—Vemurafenib—melanoma	0.000888	0.00511	CcSEcCtD
Trimipramine—Alopecia—Temozolomide—melanoma	0.000888	0.00511	CcSEcCtD
Trimipramine—Rash—Vemurafenib—melanoma	0.00088	0.00507	CcSEcCtD
Trimipramine—Dermatitis—Vemurafenib—melanoma	0.00088	0.00507	CcSEcCtD
Trimipramine—Headache—Vemurafenib—melanoma	0.000875	0.00504	CcSEcCtD
Trimipramine—Discomfort—Bleomycin—melanoma	0.000872	0.00502	CcSEcCtD
Trimipramine—Malaise—Dactinomycin—melanoma	0.000872	0.00502	CcSEcCtD
Trimipramine—Dysgeusia—Temozolomide—melanoma	0.000856	0.00493	CcSEcCtD
Trimipramine—Confusional state—Bleomycin—melanoma	0.000853	0.00491	CcSEcCtD
Trimipramine—Vision blurred—Carmustine—melanoma	0.000853	0.00491	CcSEcCtD
Trimipramine—Tremor—Carmustine—melanoma	0.000848	0.00488	CcSEcCtD
Trimipramine—Oedema—Bleomycin—melanoma	0.000846	0.00487	CcSEcCtD
Trimipramine—Agitation—Carmustine—melanoma	0.000831	0.00479	CcSEcCtD
Trimipramine—Nausea—Vemurafenib—melanoma	0.000829	0.00478	CcSEcCtD
Trimipramine—Thrombocytopenia—Bleomycin—melanoma	0.000828	0.00477	CcSEcCtD
Trimipramine—Vision blurred—Temozolomide—melanoma	0.000824	0.00475	CcSEcCtD
Trimipramine—Tremor—Temozolomide—melanoma	0.000819	0.00472	CcSEcCtD
Trimipramine—ABCB1—blood vessel—melanoma	0.000816	0.0158	CbGeAlD
Trimipramine—Discomfort—Dactinomycin—melanoma	0.000813	0.00468	CcSEcCtD
Trimipramine—Ill-defined disorder—Temozolomide—melanoma	0.000811	0.00467	CcSEcCtD
Trimipramine—Anorexia—Bleomycin—melanoma	0.000806	0.00465	CcSEcCtD
Trimipramine—Agitation—Temozolomide—melanoma	0.000803	0.00463	CcSEcCtD
Trimipramine—HRH1—eye—melanoma	0.000793	0.0154	CbGeAlD
Trimipramine—Pancytopenia—Docetaxel—melanoma	0.000792	0.00457	CcSEcCtD
Trimipramine—Hypotension—Bleomycin—melanoma	0.00079	0.00455	CcSEcCtD
Trimipramine—Oedema—Dactinomycin—melanoma	0.000789	0.00455	CcSEcCtD
Trimipramine—Malaise—Temozolomide—melanoma	0.000788	0.00454	CcSEcCtD
Trimipramine—Convulsion—Carmustine—melanoma	0.000784	0.00452	CcSEcCtD
Trimipramine—Hypertension—Carmustine—melanoma	0.000781	0.0045	CcSEcCtD
Trimipramine—SLC6A3—head—melanoma	0.000776	0.015	CbGeAlD
Trimipramine—Palpitations—Temozolomide—melanoma	0.000773	0.00445	CcSEcCtD
Trimipramine—Thrombocytopenia—Dactinomycin—melanoma	0.000772	0.00445	CcSEcCtD
Trimipramine—Anxiety—Carmustine—melanoma	0.000768	0.00442	CcSEcCtD
Trimipramine—Paraesthesia—Bleomycin—melanoma	0.00076	0.00438	CcSEcCtD
Trimipramine—Weight increased—Docetaxel—melanoma	0.000759	0.00438	CcSEcCtD
Trimipramine—Convulsion—Temozolomide—melanoma	0.000758	0.00436	CcSEcCtD
Trimipramine—HTR1D—head—melanoma	0.000757	0.0147	CbGeAlD
Trimipramine—Hypertension—Temozolomide—melanoma	0.000755	0.00435	CcSEcCtD
Trimipramine—Anorexia—Dactinomycin—melanoma	0.000752	0.00433	CcSEcCtD
Trimipramine—HTR2C—head—melanoma	0.00075	0.0145	CbGeAlD
Trimipramine—Confusional state—Carmustine—melanoma	0.000745	0.00429	CcSEcCtD
Trimipramine—Anxiety—Temozolomide—melanoma	0.000742	0.00427	CcSEcCtD
Trimipramine—Oedema—Carmustine—melanoma	0.000738	0.00425	CcSEcCtD
Trimipramine—Discomfort—Temozolomide—melanoma	0.000735	0.00424	CcSEcCtD
Trimipramine—Decreased appetite—Bleomycin—melanoma	0.000735	0.00424	CcSEcCtD
Trimipramine—Acute coronary syndrome—Docetaxel—melanoma	0.000733	0.00423	CcSEcCtD
Trimipramine—Myocardial infarction—Docetaxel—melanoma	0.000729	0.0042	CcSEcCtD
Trimipramine—Neuropathy peripheral—Docetaxel—melanoma	0.000729	0.0042	CcSEcCtD
Trimipramine—Dry mouth—Temozolomide—melanoma	0.000728	0.00419	CcSEcCtD
Trimipramine—Stomatitis—Docetaxel—melanoma	0.000725	0.00418	CcSEcCtD
Trimipramine—Jaundice—Docetaxel—melanoma	0.000725	0.00418	CcSEcCtD
Trimipramine—Thrombocytopenia—Carmustine—melanoma	0.000723	0.00417	CcSEcCtD
Trimipramine—Tachycardia—Carmustine—melanoma	0.000721	0.00415	CcSEcCtD
Trimipramine—Confusional state—Temozolomide—melanoma	0.00072	0.00415	CcSEcCtD
Trimipramine—Oedema—Temozolomide—melanoma	0.000714	0.00411	CcSEcCtD
Trimipramine—SLC6A4—head—melanoma	0.000711	0.0138	CbGeAlD
Trimipramine—Anorexia—Carmustine—melanoma	0.000704	0.00406	CcSEcCtD
Trimipramine—Thrombocytopenia—Temozolomide—melanoma	0.000699	0.00403	CcSEcCtD
Trimipramine—Feeling abnormal—Bleomycin—melanoma	0.000697	0.00402	CcSEcCtD
Trimipramine—Agranulocytosis—Docetaxel—melanoma	0.000694	0.004	CcSEcCtD
Trimipramine—Hypotension—Carmustine—melanoma	0.00069	0.00398	CcSEcCtD
Trimipramine—Decreased appetite—Dactinomycin—melanoma	0.000686	0.00395	CcSEcCtD
Trimipramine—Fatigue—Dactinomycin—melanoma	0.00068	0.00392	CcSEcCtD
Trimipramine—Anorexia—Temozolomide—melanoma	0.00068	0.00392	CcSEcCtD
Trimipramine—Urticaria—Bleomycin—melanoma	0.000672	0.00387	CcSEcCtD
Trimipramine—Body temperature increased—Bleomycin—melanoma	0.000669	0.00385	CcSEcCtD
Trimipramine—Insomnia—Carmustine—melanoma	0.000668	0.00385	CcSEcCtD
Trimipramine—Hypoaesthesia—Docetaxel—melanoma	0.000665	0.00383	CcSEcCtD
Trimipramine—Paraesthesia—Carmustine—melanoma	0.000663	0.00382	CcSEcCtD
Trimipramine—HTR2A—eye—melanoma	0.000663	0.0128	CbGeAlD
Trimipramine—HTR2A—retina—melanoma	0.000657	0.0127	CbGeAlD
Trimipramine—Somnolence—Carmustine—melanoma	0.000656	0.00378	CcSEcCtD
Trimipramine—Feeling abnormal—Dactinomycin—melanoma	0.00065	0.00375	CcSEcCtD
Trimipramine—Insomnia—Temozolomide—melanoma	0.000645	0.00372	CcSEcCtD
Trimipramine—Decreased appetite—Carmustine—melanoma	0.000642	0.0037	CcSEcCtD
Trimipramine—Paraesthesia—Temozolomide—melanoma	0.000641	0.00369	CcSEcCtD
Trimipramine—Somnolence—Temozolomide—melanoma	0.000634	0.00366	CcSEcCtD
Trimipramine—Constipation—Carmustine—melanoma	0.000631	0.00364	CcSEcCtD
Trimipramine—HTR1A—head—melanoma	0.000631	0.0122	CbGeAlD
Trimipramine—HRH1—mammalian vulva—melanoma	0.000629	0.0122	CbGeAlD
Trimipramine—Dyspepsia—Temozolomide—melanoma	0.000628	0.00362	CcSEcCtD
Trimipramine—SLC6A2—head—melanoma	0.000626	0.0121	CbGeAlD
Trimipramine—Abdominal pain—Dactinomycin—melanoma	0.000624	0.00359	CcSEcCtD
Trimipramine—Body temperature increased—Dactinomycin—melanoma	0.000624	0.00359	CcSEcCtD
Trimipramine—Decreased appetite—Temozolomide—melanoma	0.00062	0.00357	CcSEcCtD
Trimipramine—Flushing—Docetaxel—melanoma	0.00062	0.00357	CcSEcCtD
Trimipramine—ADRA2A—mammalian vulva—melanoma	0.000618	0.012	CbGeAlD
Trimipramine—Fatigue—Temozolomide—melanoma	0.000615	0.00354	CcSEcCtD
Trimipramine—Constipation—Temozolomide—melanoma	0.00061	0.00352	CcSEcCtD
Trimipramine—Feeling abnormal—Carmustine—melanoma	0.000608	0.00351	CcSEcCtD
Trimipramine—Asthenia—Bleomycin—melanoma	0.000607	0.0035	CcSEcCtD
Trimipramine—Pruritus—Bleomycin—melanoma	0.000598	0.00345	CcSEcCtD
Trimipramine—Arrhythmia—Docetaxel—melanoma	0.000597	0.00344	CcSEcCtD
Trimipramine—Alopecia—Docetaxel—melanoma	0.00059	0.0034	CcSEcCtD
Trimipramine—Feeling abnormal—Temozolomide—melanoma	0.000588	0.00339	CcSEcCtD
Trimipramine—Orphenadrine—SCN10A—melanoma	0.000586	0.124	CrCbGaD
Trimipramine—Body temperature increased—Carmustine—melanoma	0.000584	0.00336	CcSEcCtD
Trimipramine—Abdominal pain—Carmustine—melanoma	0.000584	0.00336	CcSEcCtD
Trimipramine—ADRA1A—head—melanoma	0.000582	0.0113	CbGeAlD
Trimipramine—DRD2—head—melanoma	0.00057	0.011	CbGeAlD
Trimipramine—Dysgeusia—Docetaxel—melanoma	0.000569	0.00328	CcSEcCtD
Trimipramine—Urticaria—Temozolomide—melanoma	0.000567	0.00327	CcSEcCtD
Trimipramine—Asthenia—Dactinomycin—melanoma	0.000566	0.00326	CcSEcCtD
Trimipramine—Body temperature increased—Temozolomide—melanoma	0.000564	0.00325	CcSEcCtD
Trimipramine—Abdominal pain—Temozolomide—melanoma	0.000564	0.00325	CcSEcCtD
Trimipramine—Diarrhoea—Dactinomycin—melanoma	0.00054	0.00311	CcSEcCtD
Trimipramine—Vomiting—Bleomycin—melanoma	0.000538	0.0031	CcSEcCtD
Trimipramine—Rash—Bleomycin—melanoma	0.000533	0.00307	CcSEcCtD
Trimipramine—Dermatitis—Bleomycin—melanoma	0.000533	0.00307	CcSEcCtD
Trimipramine—Asthenia—Carmustine—melanoma	0.00053	0.00305	CcSEcCtD
Trimipramine—Palpitations—Docetaxel—melanoma	0.000514	0.00296	CcSEcCtD
Trimipramine—Asthenia—Temozolomide—melanoma	0.000512	0.00295	CcSEcCtD
Trimipramine—Diarrhoea—Carmustine—melanoma	0.000505	0.00291	CcSEcCtD
Trimipramine—Pruritus—Temozolomide—melanoma	0.000505	0.00291	CcSEcCtD
Trimipramine—Convulsion—Docetaxel—melanoma	0.000504	0.0029	CcSEcCtD
Trimipramine—Nausea—Bleomycin—melanoma	0.000502	0.0029	CcSEcCtD
Trimipramine—Hypertension—Docetaxel—melanoma	0.000502	0.00289	CcSEcCtD
Trimipramine—Vomiting—Dactinomycin—melanoma	0.000502	0.00289	CcSEcCtD
Trimipramine—Rash—Dactinomycin—melanoma	0.000497	0.00287	CcSEcCtD
Trimipramine—Dizziness—Carmustine—melanoma	0.000488	0.00281	CcSEcCtD
Trimipramine—Diarrhoea—Temozolomide—melanoma	0.000488	0.00281	CcSEcCtD
Trimipramine—Dry mouth—Docetaxel—melanoma	0.000484	0.00279	CcSEcCtD
Trimipramine—Confusional state—Docetaxel—melanoma	0.000478	0.00276	CcSEcCtD
Trimipramine—Oedema—Docetaxel—melanoma	0.000475	0.00273	CcSEcCtD
Trimipramine—Dizziness—Temozolomide—melanoma	0.000472	0.00272	CcSEcCtD
Trimipramine—Vomiting—Carmustine—melanoma	0.000469	0.00271	CcSEcCtD
Trimipramine—Nausea—Dactinomycin—melanoma	0.000469	0.0027	CcSEcCtD
Trimipramine—Rash—Carmustine—melanoma	0.000466	0.00268	CcSEcCtD
Trimipramine—Dermatitis—Carmustine—melanoma	0.000465	0.00268	CcSEcCtD
Trimipramine—Thrombocytopenia—Docetaxel—melanoma	0.000465	0.00268	CcSEcCtD
Trimipramine—Tachycardia—Docetaxel—melanoma	0.000463	0.00267	CcSEcCtD
Trimipramine—Headache—Carmustine—melanoma	0.000463	0.00267	CcSEcCtD
Trimipramine—Vomiting—Temozolomide—melanoma	0.000454	0.00261	CcSEcCtD
Trimipramine—Anorexia—Docetaxel—melanoma	0.000452	0.00261	CcSEcCtD
Trimipramine—HRH1—head—melanoma	0.00045	0.00872	CbGeAlD
Trimipramine—Rash—Temozolomide—melanoma	0.00045	0.00259	CcSEcCtD
Trimipramine—Dermatitis—Temozolomide—melanoma	0.00045	0.00259	CcSEcCtD
Trimipramine—Headache—Temozolomide—melanoma	0.000447	0.00258	CcSEcCtD
Trimipramine—Hypotension—Docetaxel—melanoma	0.000443	0.00255	CcSEcCtD
Trimipramine—ADRA2A—head—melanoma	0.000442	0.00856	CbGeAlD
Trimipramine—Nausea—Carmustine—melanoma	0.000439	0.00253	CcSEcCtD
Trimipramine—SLC6A2—lymph node—melanoma	0.000438	0.00848	CbGeAlD
Trimipramine—ABCB1—retina—melanoma	0.00043	0.00833	CbGeAlD
Trimipramine—Insomnia—Docetaxel—melanoma	0.000429	0.00247	CcSEcCtD
Trimipramine—Paraesthesia—Docetaxel—melanoma	0.000426	0.00246	CcSEcCtD
Trimipramine—Nausea—Temozolomide—melanoma	0.000424	0.00244	CcSEcCtD
Trimipramine—Somnolence—Docetaxel—melanoma	0.000422	0.00243	CcSEcCtD
Trimipramine—Dyspepsia—Docetaxel—melanoma	0.000418	0.00241	CcSEcCtD
Trimipramine—Decreased appetite—Docetaxel—melanoma	0.000413	0.00238	CcSEcCtD
Trimipramine—Fatigue—Docetaxel—melanoma	0.000409	0.00236	CcSEcCtD
Trimipramine—Constipation—Docetaxel—melanoma	0.000406	0.00234	CcSEcCtD
Trimipramine—Feeling abnormal—Docetaxel—melanoma	0.000391	0.00225	CcSEcCtD
Trimipramine—HTR2A—head—melanoma	0.000376	0.00728	CbGeAlD
Trimipramine—Body temperature increased—Docetaxel—melanoma	0.000375	0.00216	CcSEcCtD
Trimipramine—Abdominal pain—Docetaxel—melanoma	0.000375	0.00216	CcSEcCtD
Trimipramine—ABCB1—mammalian vulva—melanoma	0.000345	0.00667	CbGeAlD
Trimipramine—CYP2D6—head—melanoma	0.000343	0.00663	CbGeAlD
Trimipramine—Asthenia—Docetaxel—melanoma	0.00034	0.00196	CcSEcCtD
Trimipramine—Pruritus—Docetaxel—melanoma	0.000336	0.00193	CcSEcCtD
Trimipramine—Diarrhoea—Docetaxel—melanoma	0.000325	0.00187	CcSEcCtD
Trimipramine—HRH1—lymph node—melanoma	0.000315	0.0061	CbGeAlD
Trimipramine—Dizziness—Docetaxel—melanoma	0.000314	0.00181	CcSEcCtD
Trimipramine—ADRA2A—lymph node—melanoma	0.00031	0.00599	CbGeAlD
Trimipramine—Vomiting—Docetaxel—melanoma	0.000302	0.00174	CcSEcCtD
Trimipramine—Rash—Docetaxel—melanoma	0.000299	0.00172	CcSEcCtD
Trimipramine—Dermatitis—Docetaxel—melanoma	0.000299	0.00172	CcSEcCtD
Trimipramine—Headache—Docetaxel—melanoma	0.000297	0.00171	CcSEcCtD
Trimipramine—Epinastine—ABCB1—melanoma	0.000284	0.0603	CrCbGaD
Trimipramine—Nausea—Docetaxel—melanoma	0.000282	0.00162	CcSEcCtD
Trimipramine—Oxcarbazepine—ALB—melanoma	0.000274	0.0583	CrCbGaD
Trimipramine—ABCB1—head—melanoma	0.000246	0.00477	CbGeAlD
Trimipramine—Acepromazine—ALB—melanoma	0.000207	0.044	CrCbGaD
Trimipramine—Carbamazepine—ABCB1—melanoma	0.000179	0.0379	CrCbGaD
Trimipramine—ABCB1—lymph node—melanoma	0.000173	0.00334	CbGeAlD
Trimipramine—Clomipramine—ALB—melanoma	0.000158	0.0335	CrCbGaD
Trimipramine—Nortriptyline—ALB—melanoma	0.000154	0.0327	CrCbGaD
Trimipramine—Clomipramine—ABCB1—melanoma	0.00015	0.0319	CrCbGaD
Trimipramine—Promethazine—ABCB1—melanoma	0.000133	0.0283	CrCbGaD
Trimipramine—Doxepin—ABCB1—melanoma	0.000132	0.028	CrCbGaD
Trimipramine—Methadone—ABCB1—melanoma	0.000131	0.0278	CrCbGaD
Trimipramine—Desipramine—ABCB1—melanoma	0.000121	0.0257	CrCbGaD
Trimipramine—Chlorpromazine—ALB—melanoma	0.000108	0.0229	CrCbGaD
Trimipramine—Amitriptyline—ALB—melanoma	0.000107	0.0227	CrCbGaD
Trimipramine—Chlorpromazine—ABCB1—melanoma	0.000103	0.0219	CrCbGaD
Trimipramine—Imipramine—ABCB1—melanoma	0.000103	0.0218	CrCbGaD
Trimipramine—Amitriptyline—ABCB1—melanoma	0.000102	0.0217	CrCbGaD
Trimipramine—HTR2C—Signaling by GPCR—AKT1—melanoma	8.13e-06	3.19e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—HRAS—melanoma	8.12e-06	3.19e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.06e-06	3.16e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CXCL8—melanoma	8.05e-06	3.16e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CXCL8—melanoma	8.03e-06	3.15e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MMP9—melanoma	8.02e-06	3.15e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—HRAS—melanoma	7.99e-06	3.14e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CDKN1A—melanoma	7.99e-06	3.14e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CDKN1B—melanoma	7.99e-06	3.13e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—HRAS—melanoma	7.98e-06	3.13e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PTEN—melanoma	7.98e-06	3.13e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NFKB1—melanoma	7.94e-06	3.12e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PPARG—melanoma	7.94e-06	3.11e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PIK3CA—melanoma	7.92e-06	3.11e-05	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—AKT1—melanoma	7.9e-06	3.1e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CXCL8—melanoma	7.88e-06	3.09e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTEN—melanoma	7.87e-06	3.09e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	7.86e-06	3.09e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CDKN1B—melanoma	7.86e-06	3.08e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CDKN1B—melanoma	7.84e-06	3.08e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—melanoma	7.84e-06	3.08e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MDM2—melanoma	7.83e-06	3.07e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—HRAS—melanoma	7.83e-06	3.07e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CASP3—melanoma	7.83e-06	3.07e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL2—melanoma	7.82e-06	3.07e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AKT1—melanoma	7.78e-06	3.05e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6—melanoma	7.78e-06	3.05e-05	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AKT1—melanoma	7.77e-06	3.05e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—STAT3—melanoma	7.76e-06	3.05e-05	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AKT1—melanoma	7.76e-06	3.04e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CG—melanoma	7.75e-06	3.04e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NRAS—melanoma	7.74e-06	3.04e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ERBB2—melanoma	7.72e-06	3.03e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CASP3—melanoma	7.7e-06	3.02e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CDKN1B—melanoma	7.69e-06	3.02e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL2—melanoma	7.69e-06	3.02e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CASP3—melanoma	7.69e-06	3.02e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CG—melanoma	7.68e-06	3.01e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL2—melanoma	7.67e-06	3.01e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—melanoma	7.66e-06	3.01e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6—melanoma	7.65e-06	3e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6—melanoma	7.64e-06	3e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCND1—melanoma	7.62e-06	2.99e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CB—melanoma	7.62e-06	2.99e-05	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AKT1—melanoma	7.61e-06	2.99e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—melanoma	7.56e-06	2.97e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CTNNB1—melanoma	7.54e-06	2.96e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CASP3—melanoma	7.54e-06	2.96e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL2—melanoma	7.53e-06	2.96e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—melanoma	7.53e-06	2.95e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCND1—melanoma	7.5e-06	2.94e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6—melanoma	7.49e-06	2.94e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—STAT3—melanoma	7.49e-06	2.94e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCND1—melanoma	7.48e-06	2.94e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PPARG—melanoma	7.48e-06	2.94e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NRAS—melanoma	7.47e-06	2.93e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—STAT3—melanoma	7.45e-06	2.93e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NRAS—melanoma	7.43e-06	2.92e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CTNNB1—melanoma	7.42e-06	2.91e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK3—melanoma	7.41e-06	2.91e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PPARG—melanoma	7.41e-06	2.91e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CTNNB1—melanoma	7.41e-06	2.91e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CD—melanoma	7.41e-06	2.91e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MMP9—melanoma	7.4e-06	2.9e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CDKN1A—melanoma	7.37e-06	2.89e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PTEN—melanoma	7.35e-06	2.89e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCND1—melanoma	7.34e-06	2.88e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HRAS—melanoma	7.33e-06	2.88e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CXCL8—melanoma	7.32e-06	2.87e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NFKB1—melanoma	7.32e-06	2.87e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ALB—melanoma	7.31e-06	2.87e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MMP9—melanoma	7.28e-06	2.86e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—HRAS—melanoma	7.27e-06	2.85e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CTNNB1—melanoma	7.27e-06	2.85e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MMP9—melanoma	7.26e-06	2.85e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CDKN1A—melanoma	7.25e-06	2.85e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CDKN1A—melanoma	7.24e-06	2.84e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PTEN—melanoma	7.24e-06	2.84e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CD—melanoma	7.23e-06	2.84e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PTEN—melanoma	7.22e-06	2.83e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MYC—melanoma	7.21e-06	2.83e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—melanoma	7.2e-06	2.83e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NFKB1—melanoma	7.2e-06	2.83e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NFKB1—melanoma	7.19e-06	2.82e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AKT1—melanoma	7.17e-06	2.82e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK3—melanoma	7.16e-06	2.81e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	7.15e-06	2.81e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ALB—melanoma	7.14e-06	2.8e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—STAT3—melanoma	7.13e-06	2.8e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MMP9—melanoma	7.13e-06	2.8e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK3—melanoma	7.12e-06	2.79e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NRAS—melanoma	7.12e-06	2.79e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	7.1e-06	2.79e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PTEN—melanoma	7.08e-06	2.78e-05	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	7.07e-06	2.78e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AKT1—melanoma	7.06e-06	2.77e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK1—melanoma	7.05e-06	2.77e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EGFR—melanoma	7.05e-06	2.77e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NFKB1—melanoma	7.05e-06	2.77e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AKT1—melanoma	7.04e-06	2.76e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ABCB1—melanoma	7.03e-06	2.76e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6—melanoma	7.01e-06	2.75e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CASP3—melanoma	7.01e-06	2.75e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL2—melanoma	7e-06	2.75e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6—melanoma	6.96e-06	2.73e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MYC—melanoma	6.96e-06	2.73e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MYC—melanoma	6.92e-06	2.72e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AKT1—melanoma	6.91e-06	2.71e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCND1—melanoma	6.82e-06	2.68e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK3—melanoma	6.82e-06	2.68e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CD—melanoma	6.81e-06	2.67e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK1—melanoma	6.81e-06	2.67e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EGFR—melanoma	6.81e-06	2.67e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK1—melanoma	6.77e-06	2.66e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EGFR—melanoma	6.77e-06	2.66e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	6.75e-06	2.65e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CD—melanoma	6.75e-06	2.65e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ALB—melanoma	6.72e-06	2.64e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ALB—melanoma	6.67e-06	2.62e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—KRAS—melanoma	6.66e-06	2.62e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—melanoma	6.64e-06	2.61e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MYC—melanoma	6.63e-06	2.6e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MMP9—melanoma	6.62e-06	2.6e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	6.6e-06	2.59e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTEN—melanoma	6.58e-06	2.58e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—STAT3—melanoma	6.58e-06	2.58e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NRAS—melanoma	6.56e-06	2.58e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NFKB1—melanoma	6.55e-06	2.57e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—melanoma	6.54e-06	2.57e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—melanoma	6.52e-06	2.56e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK1—melanoma	6.48e-06	2.55e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EGFR—melanoma	6.48e-06	2.54e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AKT1—melanoma	6.47e-06	2.54e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—STAT3—melanoma	6.47e-06	2.54e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PRKCA—melanoma	6.47e-06	2.54e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—STAT3—melanoma	6.46e-06	2.53e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NRAS—melanoma	6.46e-06	2.53e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CB—melanoma	6.45e-06	2.53e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NRAS—melanoma	6.44e-06	2.53e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—KRAS—melanoma	6.43e-06	2.52e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AKT1—melanoma	6.42e-06	2.52e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ERCC2—melanoma	6.41e-06	2.52e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—melanoma	6.4e-06	2.51e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—KRAS—melanoma	6.4e-06	2.51e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTGS2—melanoma	6.4e-06	2.51e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—STAT3—melanoma	6.34e-06	2.49e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NRAS—melanoma	6.32e-06	2.48e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CB—melanoma	6.3e-06	2.47e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK3—melanoma	6.28e-06	2.47e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTGS2—melanoma	6.24e-06	2.45e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK3—melanoma	6.18e-06	2.43e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK3—melanoma	6.17e-06	2.42e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—KRAS—melanoma	6.12e-06	2.4e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PIK3CA—melanoma	6.12e-06	2.4e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MYC—melanoma	6.11e-06	2.4e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK3—melanoma	6.05e-06	2.38e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MYC—melanoma	6.01e-06	2.36e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MYC—melanoma	6e-06	2.36e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK1—melanoma	5.98e-06	2.35e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EGFR—melanoma	5.98e-06	2.35e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—melanoma	5.95e-06	2.33e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CB—melanoma	5.94e-06	2.33e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—melanoma	5.92e-06	2.32e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PIK3CA—melanoma	5.91e-06	2.32e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MYC—melanoma	5.89e-06	2.31e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—STAT3—melanoma	5.89e-06	2.31e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CB—melanoma	5.89e-06	2.31e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK1—melanoma	5.88e-06	2.31e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTGS2—melanoma	5.88e-06	2.31e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EGFR—melanoma	5.88e-06	2.31e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PIK3CA—melanoma	5.88e-06	2.31e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NRAS—melanoma	5.87e-06	2.31e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK1—melanoma	5.87e-06	2.3e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EGFR—melanoma	5.87e-06	2.3e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTGS2—melanoma	5.83e-06	2.29e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK1—melanoma	5.76e-06	2.26e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EGFR—melanoma	5.76e-06	2.26e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—melanoma	5.72e-06	2.24e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—melanoma	5.69e-06	2.23e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HRAS—melanoma	5.66e-06	2.22e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—KRAS—melanoma	5.65e-06	2.22e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	5.63e-06	2.21e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK3—melanoma	5.62e-06	2.21e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTEN—melanoma	5.58e-06	2.19e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—KRAS—melanoma	5.56e-06	2.18e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PIK3CA—melanoma	5.55e-06	2.18e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—KRAS—melanoma	5.54e-06	2.18e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MYC—melanoma	5.47e-06	2.15e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HRAS—melanoma	5.47e-06	2.15e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTEN—melanoma	5.44e-06	2.14e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—melanoma	5.44e-06	2.14e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KRAS—melanoma	5.44e-06	2.14e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HRAS—melanoma	5.44e-06	2.13e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6—melanoma	5.42e-06	2.13e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK1—melanoma	5.35e-06	2.1e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EGFR—melanoma	5.35e-06	2.1e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6—melanoma	5.23e-06	2.05e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HRAS—melanoma	5.21e-06	2.04e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6—melanoma	5.21e-06	2.04e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PIK3CA—melanoma	5.19e-06	2.04e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTEN—melanoma	5.13e-06	2.01e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PIK3CA—melanoma	5.1e-06	2e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PIK3CA—melanoma	5.09e-06	2e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTEN—melanoma	5.09e-06	2e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CG—melanoma	5.07e-06	1.99e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KRAS—melanoma	5.05e-06	1.98e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—melanoma	5.02e-06	1.97e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AKT1—melanoma	5e-06	1.96e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	5e-06	1.96e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6—melanoma	4.98e-06	1.96e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—melanoma	4.94e-06	1.94e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—melanoma	4.93e-06	1.93e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PPARG—melanoma	4.89e-06	1.92e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—melanoma	4.84e-06	1.9e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AKT1—melanoma	4.83e-06	1.89e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AKT1—melanoma	4.8e-06	1.88e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HRAS—melanoma	4.8e-06	1.88e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HRAS—melanoma	4.72e-06	1.85e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HRAS—melanoma	4.71e-06	1.85e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	4.64e-06	1.82e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HRAS—melanoma	4.62e-06	1.82e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AKT1—melanoma	4.6e-06	1.8e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6—melanoma	4.59e-06	1.8e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AKT1—melanoma	4.54e-06	1.78e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6—melanoma	4.52e-06	1.77e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6—melanoma	4.51e-06	1.77e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—melanoma	4.49e-06	1.76e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CD—melanoma	4.45e-06	1.75e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6—melanoma	4.43e-06	1.74e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ALB—melanoma	4.4e-06	1.73e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HRAS—melanoma	4.3e-06	1.69e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AKT1—melanoma	4.24e-06	1.66e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AKT1—melanoma	4.17e-06	1.64e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AKT1—melanoma	4.16e-06	1.63e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6—melanoma	4.11e-06	1.61e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AKT1—melanoma	4.08e-06	1.6e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CA—melanoma	3.93e-06	1.54e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CB—melanoma	3.88e-06	1.52e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTGS2—melanoma	3.85e-06	1.51e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CA—melanoma	3.84e-06	1.51e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AKT1—melanoma	3.79e-06	1.49e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CA—melanoma	3.62e-06	1.42e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CA—melanoma	3.59e-06	1.41e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTEN—melanoma	3.35e-06	1.32e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AKT1—melanoma	3.21e-06	1.26e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AKT1—melanoma	3.14e-06	1.23e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AKT1—melanoma	2.96e-06	1.16e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AKT1—melanoma	2.93e-06	1.15e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CA—melanoma	2.37e-06	9.29e-06	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AKT1—melanoma	1.93e-06	7.59e-06	CbGpPWpGaD
